Investors | Syncona

Unless stated all financials at 31 December 2024

£1.1bn

Net assets

179p

NAV per share

(4.9)%

NAV per share return in the year

£780m

Value of life science portfolio

(9.5)%

Return from life science portfolio in the year

£345m

Capital pool

Transaction in Own Shares

14.03.25

Transaction in Own Shares

13.03.25

Transaction in Own Shares

12.03.25

Transaction in Own Shares

11.03.25

Transaction in Own Shares

10.03.25

Transaction in Own Shares

07.03.25

Transaction in Own Shares

06.03.25

Transaction in Own Shares

05.03.25

Holding(s) in Company

04.03.25

Transaction in Own Shares

04.03.25

Total Voting Rights

03.03.25

Transaction in Own Shares

03.03.25

Transaction in Own Shares

28.02.25

Transaction in Own Shares

27.02.25

Transaction in Own Shares

26.02.25

Transaction in Own Shares

25.02.25

Transaction in Own Shares

24.02.25

Transaction in Own Shares

21.02.25